<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01586299</url>
  </required_header>
  <id_info>
    <org_study_id>262-11-RMC</org_study_id>
    <nct_id>NCT01586299</nct_id>
  </id_info>
  <brief_title>NSAIDs Treatment in Children With Pleuropneumonia</brief_title>
  <official_title>The Role of Non Steroidal Anti Inflammatory Drugs in the Treatment of Pleuropneumonia in Children. a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rabin Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rabin Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the influence of routine NSAIDs treatment for
      hospitalized children with pleuropneumonia in comparison with acetominophen treatment (all in
      conjunction with adequate antibiotic therapy).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>clinical improvement as manifested by resolution of fever and length of hospital admission.</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 10 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>clinical improvement as manifested by respiratory parameters (tachypnea, dyspnea, Fio2),and inflammatory markers.</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 10 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pleuro-pneumonia</condition>
  <arm_group>
    <arm_group_label>ibuprofen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <description>10 mg/kg every 8 hours until 24 hours after resolution of fever</description>
    <arm_group_label>ibuprofen</arm_group_label>
    <other_name>nurofen</other_name>
    <other_name>advil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>15 mg/kg every 6 hours until 24 hours after resolution of fever</description>
    <arm_group_label>acetaminophen</arm_group_label>
    <other_name>paracetamol</other_name>
    <other_name>acamol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age less than 18 years

          -  admission in Schneider childrenMC of Israel, wards a/c

          -  clinical diagnosis of pneumonia with evidence of pleural effusion on chest X-ray

          -  parental informed consent

          -  follow-up ability after discharge

        Exclusion Criteria:

          -  pneumonia secondary to foreign body aspiration

          -  immune deficiency

          -  chronic lung disease other than asthma (CF, CLD of prematurity, Familial Dysautonomia,
             etc)

          -  significant premorbidity (organ failure, rheumatic disease, etc)

          -  endotracheal/endobronchial devices including tracheostomy.

          -  parental refusal to participate in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>havatzelet yarden-bilavsky, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>schneider children MC of Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>shai ashkenazi, Prof</last_name>
    <phone>972-3-9253680</phone>
    <email>sashkenazi@clalit.org.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>havatzelet yarden-bilavsky, Dr</last_name>
    <phone>972-54-6777054</phone>
    <email>yojiby@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Schneider's medical center of Israel</name>
      <address>
        <city>Petah Tikva</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Havatzelet -- Yarden-Bilavski, MD</last_name>
      <phone>+972-3-9253680</phone>
      <email>yoji@netvision.net.il</email>
    </contact>
    <investigator>
      <last_name>Havatzelet -- Yarden-Bilavski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 19, 2012</study_first_submitted>
  <study_first_submitted_qc>April 25, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 26, 2012</study_first_posted>
  <last_update_submitted>November 13, 2014</last_update_submitted>
  <last_update_submitted_qc>November 13, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 14, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pleuropneumonia children</keyword>
  <keyword>non steroidal anti inflammatory drugs</keyword>
  <keyword>pleural effusion</keyword>
  <keyword>severe pneumonia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Pleuropneumonia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Anti-Inflammatory Agents, Non-Steroidal</mesh_term>
    <mesh_term>Anti-Inflammatory Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

